A review on cholinesterase inhibitors for Alzheimer's disease.
about
Therapies for Prevention and Treatment of Alzheimer's DiseaseAn overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsA Review on Potential Mechanisms of Terminalia chebula in Alzheimer's DiseaseAlzheimer's disease--a panorama glimpseFermented Sipjeondaebo-tang Alleviates Memory Deficits and Loss of Hippocampal Neurogenesis in Scopolamine-induced Amnesia in Mice.Key Targets for Multi-Target Ligands Designed to Combat NeurodegenerationMolecular investigations of protriptyline as a multi-target directed ligand in Alzheimer's diseaseA wrench in the works of human acetylcholinesterase: soman induced conformational changes revealed by molecular dynamics simulationsGorge Motions of Acetylcholinesterase Revealed by Microsecond Molecular Dynamics Simulations.Cardiovascular effects of drugs used to treat Alzheimer's disease.A comparative study of the effect of the dose and exposure duration of anabolic androgenic steroids on behavior, cholinergic regulation, and oxidative stress in ratsMultipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybridsDesign of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer disease.Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery diseaseMultitarget-directed tricyclic pyridazinones as G protein-coupled receptor ligands and cholinesterase inhibitors.Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled TrialsMolecular Docking Study on Galantamine Derivatives as Cholinesterase Inhibitors.The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled TrialFucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in VitroOver-Prescribed Medications, Under-Appreciated Risks: A Review of the Cognitive Effects of Anticholinergic Medications in Older Adults.Antidepressants for neuro-regeneration: from depression to Alzheimer's disease.Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.The role of positron emission tomography imaging in understanding Alzheimer's disease.Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.3-(Benzyloxy)-1-(5-[18F]fluoropentyl)-5-nitro-1H-indazole: a PET radiotracer to measure acetylcholinesterase in brain.Acetylcholinesterase enzyme inhibitor activity of some novel pyrazinamide condensed 1,2,3,4-tetrahydropyrimidines.Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia.Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy.Role of σ1 Receptors in Learning and Memory and Alzheimer's Disease-Type Dementia.Toxicological Differences Between NMDA Receptor Antagonists and Cholinesterase Inhibitors.Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil.Schiff bases in medicinal chemistry: a patent review (2010-2015).Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice.Research Advances and Detection Methodologies for Microbe-Derived Acetylcholinesterase Inhibitors: A Systemic Review.Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.A Novel Small Molecule Modulator of Amyloid Pathology.Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP.Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain.
P2860
Q26740007-1530A552-B59A-4A65-AA35-59E68CA59128Q26751302-9C32C1C5-AA40-44E9-9BC3-36D758A163F5Q26864964-7F7C072F-364C-4748-A16C-69CC00095BBBQ27011749-CA696C42-AEF0-4557-B0C7-00DD3DAF55A3Q27335037-5159EBB7-5CF5-4592-80AB-866E1F9A1CADQ28077589-2AD15E72-99D6-4EFA-B323-156300726FA3Q28542431-615A1A30-35F7-4C66-B82D-AE5A1E18A84FQ28546253-F819CBD6-7488-4428-A5EE-A08FA26FCB19Q30403000-BADCF2E9-5670-4276-B453-0B7F454219C7Q33164224-E280D765-C61B-4E01-BA79-19755DFEC706Q33778317-B87149AB-ACE4-4C2F-B62C-B3C846B6241AQ34394212-CD660A91-4BBD-4DA8-B83C-060B2557E2C6Q34583429-E30C5441-2AA2-4789-A367-03CFDA5AF53CQ35002786-D27764D1-D6E8-4ED8-861E-E97A1ACCD6C4Q35341268-3BA50288-0E07-4B64-98D2-2B0E050EF2C9Q35618019-81242698-219A-42E7-BEF5-10D02543D630Q35669030-B7B9E378-1118-4ED6-9B09-81B192B7AA32Q36094892-50C3F984-3AC4-4BF5-86C6-D0562021C623Q36829198-7240B6B9-E62C-4163-8110-340DCEB20242Q36847332-ACC79ABE-C914-4949-A494-D64FC2B3376FQ37446075-91BE01BE-7F5C-485F-A0EB-7FCEE0E1D0F7Q38152966-CF246A02-D47B-42F7-97E9-2C85DD52E7B2Q38229311-C2283380-E38E-4B04-870B-0FF5A29A8463Q38370609-BCF7B589-96E2-451E-B4FC-4EFDEF16AF2BQ38661735-F244B97F-472D-432D-A742-6CEA9A482A2AQ38669027-C2C407FA-723A-4279-82A2-86CBBB82A92AQ38720075-F513CDBB-0E1A-42B9-B891-328C1C519DCCQ38737187-DF6FF796-A6E8-4DBF-828E-D87384A14742Q38806779-1DF16D5B-2427-4D80-B305-7F36A6A8DC3AQ38896662-4E8C783B-DC16-430E-B7C3-C3F6AC58E6EEQ38920515-5165AFAA-1C3B-44B7-9B6D-8AFF4847FE35Q38951854-1FEE9279-50AC-4960-9320-778862184E11Q38989218-5C5E1C74-7BC6-4964-8CC0-8DEAB7C7B669Q39054244-514E5768-2299-4F77-ABA6-E83B3BD4A69DQ39104475-01285EA2-A737-4658-B871-CD2318ED7280Q39108867-3893E457-2E4A-4001-B2CF-57AEB47891A8Q39779155-0E7DD47B-5AE5-4799-804E-8EA3D901966FQ40390510-6389787F-680E-4465-86FD-DD84CF899E00Q40964337-7D352E57-5AF7-48AC-B0B5-D37A8034E081Q41585067-C249B510-CFE8-44A5-9E0C-6680752F60B5
P2860
A review on cholinesterase inhibitors for Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A review on cholinesterase inhibitors for Alzheimer's disease.
@en
type
label
A review on cholinesterase inhibitors for Alzheimer's disease.
@en
prefLabel
A review on cholinesterase inhibitors for Alzheimer's disease.
@en
P2860
P1476
A review on cholinesterase inhibitors for Alzheimer's disease.
@en
P2093
Baldev Singh
Preet Anand
P2860
P2888
P304
P356
10.1007/S12272-013-0036-3
P577
2013-02-24T00:00:00Z
P6179
1048926112